ArticleVaccine2022

Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States.

Sarah A Hook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.